Unknown

Dataset Information

0

NMR Structural Studies of Antimicrobial Peptides: LPcin Analogs.


ABSTRACT: Lactophoricin (LPcin), a component of proteose peptone (113-135) isolated from bovine milk, is a cationic amphipathic antimicrobial peptide consisting of 23 amino acids. We designed a series of N- or C-terminal truncated variants, mutated analogs, and truncated mutated analogs using peptide-engineering techniques. Then, we selected three LPcin analogs of LPcin-C8 (LPcin-YK1), LPcin-T2WT6W (LPcin-YK2), and LPcin-T2WT6W-C8 (LPcin-YK3), which may have better antimicrobial activities than LPcin, and successfully expressed them in E. coli with high yield. We elucidated the 3D structures and topologies of the three LPcin analogs in membrane environments by conducting NMR structural studies. We investigated the purity of the LPcin analogs and the ?-helical secondary structures by performing (1)H-(15)N 2D HSQC and HMQC-NOESY liquid-state NMR spectroscopy using protein-containing micelle samples. We measured the 3D structures and tilt angles in membranes by conducting (15)N 1D and 2D (1)H-(15)N SAMMY type solid-state NMR spectroscopy with an 800 MHz in-house-built (1)H-(15)N double-resonance solid-state NMR probe with a strip-shield coil, using protein-containing large bicelle samples aligned and confirmed by molecular-dynamics simulations. The three LPcin analogs were found to be curved ?-helical structures, with tilt angles of 55-75° for normal membrane bilayers, and their enhanced activities may be correlated with these topologies.

SUBMITTER: Jeong JH 

PROVIDER: S-EPMC4724650 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

NMR Structural Studies of Antimicrobial Peptides: LPcin Analogs.

Jeong Ji-Ho JH   Kim Ji-Sun JS   Choi Sung-Sub SS   Kim Yongae Y  

Biophysical journal 20160101 2


Lactophoricin (LPcin), a component of proteose peptone (113-135) isolated from bovine milk, is a cationic amphipathic antimicrobial peptide consisting of 23 amino acids. We designed a series of N- or C-terminal truncated variants, mutated analogs, and truncated mutated analogs using peptide-engineering techniques. Then, we selected three LPcin analogs of LPcin-C8 (LPcin-YK1), LPcin-T2WT6W (LPcin-YK2), and LPcin-T2WT6W-C8 (LPcin-YK3), which may have better antimicrobial activities than LPcin, and  ...[more]

Similar Datasets

| S-EPMC7662265 | biostudies-literature
| S-EPMC4961720 | biostudies-literature
| S-EPMC3013618 | biostudies-literature
| S-EPMC7699717 | biostudies-literature
| S-EPMC4426897 | biostudies-literature
2018-09-15 | GSE113347 | GEO
| S-EPMC7911593 | biostudies-literature
| S-EPMC10585156 | biostudies-literature
| S-EPMC3309561 | biostudies-literature
| S-EPMC3992131 | biostudies-literature